325 related articles for article (PubMed ID: 21557689)
21. Comparison of glyburide and insulin in women with gestational diabetes mellitus and associated perinatal outcome: a randomized clinical trial.
Mirzamoradi M; Heidar Z; Faalpoor Z; Naeiji Z; Jamali R
Acta Med Iran; 2015; 53(2):97-103. PubMed ID: 25725178
[TBL] [Abstract][Full Text] [Related]
22. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
Durnwald CP; Landon MB
J Matern Fetal Neonatal Med; 2008 May; 21(5):309-13. PubMed ID: 18446657
[TBL] [Abstract][Full Text] [Related]
23. [Amniotic fluid insulin levels versus mean maternal blood glucose levels in gestational diabetes mellitus: an analysis of the neonatal outcome].
Holzapfel-Bauer M; Magnet E; Eder M; Haas J; Desoye G; Lang U
Gynakol Geburtshilfliche Rundsch; 2009; 49(4):249-53. PubMed ID: 20530937
[TBL] [Abstract][Full Text] [Related]
24. [Effect of betamethasone in blood glucose levels in pregnant diabetic women at risk of preterm birth].
Ramírez-Torres MA; Pérez-Monter SE; Espino y Sosa S; Ibargüengoitia-Ochoa F
Ginecol Obstet Mex; 2011 Sep; 79(9):565-71. PubMed ID: 21966858
[TBL] [Abstract][Full Text] [Related]
25. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study.
Balani J; Hyer SL; Rodin DA; Shehata H
Diabet Med; 2009 Aug; 26(8):798-802. PubMed ID: 19709150
[TBL] [Abstract][Full Text] [Related]
26. Recurrence of gestational diabetes mellitus: identification of risk factors.
Spong CY; Guillermo L; Kuboshige J; Cabalum T
Am J Perinatol; 1998 Jan; 15(1):29-33. PubMed ID: 9475684
[TBL] [Abstract][Full Text] [Related]
27. Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study.
Balaji V; Balaji MS; Alexander C; Srinivasan A; Suganthi SR; Thiyagarajah A; Seshiah V
Gynecol Endocrinol; 2012 Jul; 28(7):529-32. PubMed ID: 22468861
[TBL] [Abstract][Full Text] [Related]
28. [Factors relevant to newborn birth weight in pregnancy complicated with abnormal glucose metabolism].
Yang YD; Zhai GR; Yang HX
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):646-51. PubMed ID: 21092542
[TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis.
Liang HL; Ma SJ; Xiao YN; Tan HZ
Medicine (Baltimore); 2017 Sep; 96(38):e7939. PubMed ID: 28930827
[TBL] [Abstract][Full Text] [Related]
30. Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics.
Fang YM; MacKeen D; Egan JF; Zelop CM
J Matern Fetal Neonatal Med; 2009 Mar; 22(3):249-53. PubMed ID: 19330710
[TBL] [Abstract][Full Text] [Related]
31. Large-for-gestational-age newborns in women with insulin-treated gestational diabetes under strict metabolic control.
Leipold H; Worda C; Gruber CJ; Kautzky-Willer A; Husslein PW; Bancher-Todesca D
Wien Klin Wochenschr; 2005 Aug; 117(15-16):521-5. PubMed ID: 16160802
[TBL] [Abstract][Full Text] [Related]
32. The effectiveness of glibenclamide in women with gestational diabetes.
Holt RI; Clarke P; Parry EC; Coleman MA
Diabetes Obes Metab; 2008 Sep; 10(10):906-11. PubMed ID: 18093212
[TBL] [Abstract][Full Text] [Related]
33. Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial.
Niromanesh S; Alavi A; Sharbaf FR; Amjadi N; Moosavi S; Akbari S
Diabetes Res Clin Pract; 2012 Dec; 98(3):422-9. PubMed ID: 23068960
[TBL] [Abstract][Full Text] [Related]
34. A retrospective review of glargine use in pregnancy.
Henderson CE; Machupalli S; Marcano-Vasquez H; Kerr P; Reilly KD
J Reprod Med; 2009 Apr; 54(4):208-10. PubMed ID: 19438161
[TBL] [Abstract][Full Text] [Related]
35. [Hypoglycemia in the newborns of women with diabetes mellitus].
Hernández-Herrera R; Castillo-Martínez N; Banda-Torres ME; Alcalá-Galván G; Tamez-Pérez HE; Forsbach-Sánchez G
Rev Invest Clin; 2006; 58(4):285-8. PubMed ID: 17146939
[TBL] [Abstract][Full Text] [Related]
36. Detection of pregnancies with high risk of fetal macrosomia among women with gestational diabetes mellitus.
Suhonen L; Hiilesmaa V; Kaaja R; Teramo K
Acta Obstet Gynecol Scand; 2008; 87(9):940-5. PubMed ID: 18728914
[TBL] [Abstract][Full Text] [Related]
37. Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis.
Guo L; Ma J; Tang J; Hu D; Zhang W; Zhao X
J Diabetes Res; 2019; 2019():9804708. PubMed ID: 31781670
[TBL] [Abstract][Full Text] [Related]
38. A prospective controlled study of neonatal morbidities in infants born at 36 weeks or more gestation to Women with diet-controlled gestational diabetes (GDM-class Al).
Sarkar S; Watman J; Seigel WM; Schaeffer HA
J Perinatol; 2003; 23(3):223-8. PubMed ID: 12732860
[TBL] [Abstract][Full Text] [Related]
39. Predictors of glyburide failure in the treatment of gestational diabetes.
Kahn BF; Davies JK; Lynch AM; Reynolds RM; Barbour LA
Obstet Gynecol; 2006 Jun; 107(6):1303-9. PubMed ID: 16738156
[TBL] [Abstract][Full Text] [Related]
40. The effect of maternal obesity on pregnancy outcomes of women with gestational diabetes controlled with diet only, glyburide, or insulin.
Joy S; Roman A; Istwan N; Rhea D; Desch C; Stanziano G; Saltzman D
Am J Perinatol; 2012 Sep; 29(8):643-8. PubMed ID: 22644829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
